Literature DB >> 24169860

Effect of endorectal balloon positioning errors on target deformation and dosimetric quality during prostate SBRT.

Bernard L Jones1, Gregory Gan, Brian Kavanagh, Moyed Miften.   

Abstract

An inflatable endorectal balloon (ERB) is often used during stereotactic body radiation therapy (SBRT) for treatment of prostate cancer in order to reduce both intrafraction motion of the target and risk of rectal toxicity. However, the ERB can exert significant force on the prostate, and this work assessed the impact of ERB position errors on deformation of the prostate and treatment dose metrics. Seventy-one cone-beam computed tomography (CBCT) image datasets of nine patients with clinical stage T1cN0M0 prostate cancer were studied. An ERB (Flexi-Cuff, EZ-EM, Westbury, NY) inflated with 60 cm(3) of air was used during simulation and treatment, and daily kilovoltage (kV) CBCT imaging was performed to localize the prostate. The shape of the ERB in each CBCT was analyzed to determine errors in position, size, and shape. A deformable registration algorithm was used to track the dose received by (and deformation of) the prostate, and dosimetric values such as D95, PTV coverage, and Dice coefficient for the prostate were calculated. The average balloon position error was 0.5 cm in the inferior direction, with errors ranging from 2 cm inferiorly to 1 cm superiorly. The prostate was deformed primarily in the AP direction, and tilted primarily in the anterior-posterior/superior-inferior plane. A significant correlation was seen between errors in depth of ERB insertion (DOI) and mean voxel-wise deformation, prostate tilt, Dice coefficient, and planning-to-treatment prostate inter-surface distance (p < 0.001). Dosimetrically, DOI is negatively correlated with prostate D95 and PTV coverage (p < 0.001). For the model of ERB studied, error in ERB position can cause deformations in the prostate that negatively affect treatment, and this additional aspect of setup error should be considered when ERBs are used for prostate SBRT. Before treatment, the ERB position should be verified, and the ERB should be adjusted if the error is observed to exceed tolerable values.

Entities:  

Mesh:

Year:  2013        PMID: 24169860     DOI: 10.1088/0031-9155/58/22/7995

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  6 in total

Review 1.  Effectiveness of rectal displacement devices in managing prostate motion: a systematic review.

Authors:  Mahdieh Afkhami Ardekani; Hamed Ghaffari; Mahmoud Navaser; Seyed Hamid Zoljalali Moghaddam; Soheila Refahi
Journal:  Strahlenther Onkol       Date:  2020-05-22       Impact factor: 3.621

2.  PEG spacer gel and adaptive planning vs single plan in external prostate radiotherapy--clinical dosimetry evaluation.

Authors:  Vesa-Pekka Heikkilä
Journal:  Br J Radiol       Date:  2015-09-15       Impact factor: 3.039

3.  Spatial and dosimetric evaluation of residual distortions of prostate and seminal vesicle bed after image-guided definitive and postoperative radiotherapy of prostate cancer with endorectal balloon.

Authors:  Sabine Levegrün; Christoph Pöttgen; Konstantinos Xydis; Maja Guberina; Jehad Abu Jawad; Martin Stuschke
Journal:  J Appl Clin Med Phys       Date:  2020-12-30       Impact factor: 2.102

4.  Adaptive radiotherapy and the dosimetric impact of inter- and intrafractional motion on the planning target volume for prostate cancer patients.

Authors:  Felix Böckelmann; Florian Putz; Karoline Kallis; Sebastian Lettmaier; Rainer Fietkau; Christoph Bert
Journal:  Strahlenther Onkol       Date:  2020-03-10       Impact factor: 3.621

5.  Application of rectal retractor for postprostatectomy salvage radiotherapy of prostate cancer: A case report and literature review.

Authors:  Hamed Ghaffari; Mahdieh Afkhami Ardekani; Seyed Hadi Molana; Mohammad Haghparast; Mastaneh Sanei; Seied Rabi Mahdavi; Bahram Mofid; Aram Rostami
Journal:  Clin Case Rep       Date:  2019-09-27

6.  Clinical effects of rectal retractor application in prostate cancer radiotherapy.

Authors:  Amir Mohammad Arefpour; Mahshid Abbasi; Seied Rabi Mahdavi; Mahdiyeh Shafieesabet; Pedram Fadavi
Journal:  Med J Islam Repub Iran       Date:  2021-05-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.